產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱(chēng)及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
134964-100MG |
|
1194050-23-1 |
[(1,2,5,6-η)-1,5-環(huán)辛二烯][(4S)-2-[(5S)-6-(二苯基膦-κP)螺[4.4]壬-1,6-二烯-1-基]-4,5-二氫-4-異丙基惡唑-κN3]-(+)-銥(I) 四[3,5-二(三氟甲基)苯基]硼酸酯 [(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(1-methylethyl)oxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C35H42IrNOP . C32H12BF24 | |
134964-25MG |
|
1194050-23-1 |
[(1,2,5,6-η)-1,5-環(huán)辛二烯][(4S)-2-[(5S)-6-(二苯基膦-κP)螺[4.4]壬-1,6-二烯-1-基]-4,5-二氫-4-異丙基惡唑-κN3]-(+)-銥(I) 四[3,5-二(三氟甲基)苯基]硼酸酯 [(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(1-methylethyl)oxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C35H42IrNOP . C32H12BF24 | |
200215-100MG |
|
944836-22-0 |
(4S)-2-[2-[雙[4-(三氟甲基)苯基]膦]-5-(三氟甲基)苯基]-4-叔丁基-4,5-二氫惡唑 (4S)-2-[2-[Bis[4-(trifluoromethyl)phenyl]phosphino]-5-(trifluoromethyl)phenyl]-4-tert-butyl-4,5-dihydrooxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e |
100MG | 需詢(xún)價(jià) | C28H23F9NOP | |
200214-100MG |
|
1006708-91-3 |
(4R)-2-[2-[雙[4-(三氟甲基)苯基]膦]-5-(三氟甲基)苯基]-4-叔丁基-4,5-二氫惡唑 (4R)-2-[2-[Bis[4-(trifluoromethyl)phenyl]phosphino]-5-(trifluoromethyl)phenyl]-4-tert-butyl-4,5-dihydrooxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e |
100MG | 需詢(xún)價(jià) | C28H23F9NOP | |
135918-100MG |
|
148461-14-7 |
(4S)-2-[2-(二苯基膦)苯基]-4,5-二氫-4-異丙基惡唑 (4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(1-methylethyl)oxazole 請(qǐng)咨詢(xún) 大賽璐 ≥95%,- |
100MG | 需詢(xún)價(jià) | C24H24NOP | |
135919-100MG |
|
164858-78-0 |
(4R)-2-[2-(二苯基膦)苯基]-4,5-二氫-4-異丙基惡唑 (4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(1-methylethyl)oxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C24H24NOP | |
135922-100MG |
|
148461-16-9 |
(4S)-4-叔丁基-2-[2-(二苯基膦)苯基]-4,5-二氫惡唑 (4S)-4-(1,1-Dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C25H26NOP | |
135923-100MG |
|
164858-79-1 |
(4R)-4-叔丁基-2-[2-(二苯基膦)苯基]-4,5-二氫惡唑 (4R)-4-(1,1-Dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C25H26NOP | |
135924-100MG |
|
148461-13-6 |
(4S)-2-[2-二苯基膦)苯基]-4,5-二氫-4-(苯基甲基)惡唑 (4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(phenylmethyl)oxazole 請(qǐng)咨詢(xún) 大賽璐 ≥95%,99%e.e. |
100MG | 需詢(xún)價(jià) | C28H24NOP | |
135925-100MG |
|
314020-70-7 |
(4R)-2-[2-二苯基膦)苯基]-4,5-二氫-4-(苯基甲基)惡唑 (4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(phenylmethyl)oxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C28H24NOP | |
135920-100MG |
|
148461-15-8 |
(4S)-2-[2-(二苯基膦)苯基]-4,5-二氫-4-苯基惡唑 (4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C27H22NOP | |
135921-100MG |
|
167171-03-1 |
(4R)-2-[2-(二苯基膦)苯基]-4,5-二氫-4-苯基惡唑 (4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C27H22NOP | |
200189-100MG |
|
503538-70-3 |
1,1'-[(4S)-2,2,2',2'-四氟[4,4'-二-1,3-亞甲二氧基苯]-5,5'-二基]雙[1,1-二苯基膦] 1,1'-[(4S)-2,2,2',2'-Tetrafluoro[4,4'-bi-1,3-benzodioxole]-5,5'-diyl]bis[1,1-diphenylphosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C38H24F4O4P2 | |
200188-100MG |
|
503538-69-0 |
1,1'-[(4R)-2,2,2',2'-四氟[4,4'-二-1,3-亞甲二氧基苯]-5,5'-二基]雙[1,1-二苯基膦] 1,1'-[(4R)-2,2,2',2'-Tetrafluoro[4,4'-bi-1,3-benzodioxole]-5,5'-diyl]bis[1,1-diphenylphosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C38H24F4O4P2 | |
200383-100MG |
|
1310054-14-8 |
1,1'-[(1S)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-二(4-氯苯基)膦] 1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-chlorophenyl)phosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C38H28Cl4O2P2 | |
200382-100MG |
|
1310054-04-6 |
1,1'-[(1R)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-二(4-氯苯基)膦] 1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-chlorophenyl)phosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C38H28Cl4O2P2 | |
200381-100MG |
|
NA |
1,1'-[(1S)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-二-1-萘基膦] 1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-1-naphthalenylphosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C54H40O2P2 | |
200380-100MG |
|
NA |
1,1'-[(1R)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-二-1-萘基膦] 1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-1-naphthalenylphosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C54H40O2P2 | |
200379-100MG |
|
849239-14-1 |
1,1'-[(1S)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-二-2-萘基膦] 1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-2-naphthalenylphosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C54H40O2P2 | |
200378-100MG |
|
256390-46-2 |
1,1'-[(1R)-6,6'-二甲氧基[1,1'-聯(lián)苯]-2,2'-二基]雙[1,1-二-2-萘基膦] 1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-2-naphthalenylphosphine] 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C54H40O2P2 | |